Björn Walse (@bwalse) header
Björn Walse (@bwalse) profile picture

Co-founder, owner and CEO of SARomics Biostructures

Lund, Sweden
Joined November 2010
Photo by Björn Walse (@bwalse)Photo by Björn Walse (@bwalse)Photo by Björn Walse (@bwalse)Photo by Björn Walse (@bwalse)Photo by Björn Walse (@bwalse)Photo by Björn Walse (@bwalse)Photo by Björn Walse (@bwalse)Photo by Björn Walse (@bwalse)Photo by Björn Walse (@bwalse)Photo by Björn Walse (@bwalse)
Björn Walse retweeted
One week to deadline! Postdoc position in the MX group @MAXIVLaboratory, fantastic opportunity for advancing serial crystallography fragment screening at MicroMAX. Apply here lu.varbi.com/en/what:job/job…
3
1
6
978
⚙️#ResearchEngineer wanted for the MAX IV #FragMAX facility! You will join the #macromolecular crystallography (MX) group in supporting our growing #academic and #industrial user program. Learn more about this exciting role ->lu.varbi.com/en/what:job/job… #xrays #research #job #apply
5
1
6
1,301
Proud to see the beautiful cover of TiPS made by @icaro_simon.
The December 2023 issue of Cell Press Trends in Pharmacological Sciences is online now. cell.com/trends/pharmacologi… On the cover: Ligand selectivity hotspots in serotonin GPCRs @icaro_simon @David_Gloriam @waldensciencing @Lundbeckfonden @UCPH_health
2
11
836
The December 2023 issue of Cell Press Trends in Pharmacological Sciences is online now. cell.com/trends/pharmacologi… On the cover: Ligand selectivity hotspots in serotonin GPCRs @icaro_simon @David_Gloriam @waldensciencing @Lundbeckfonden @UCPH_health
17
1
48
5,100
Björn Walse retweeted
Perfect time to join #MicroMAX as we are starting user operation and continue to develop new instruments and methods!
The Macromolecular Crystallography group seeks a #BeamlineScientist at #MicroMAX beamline! The beamline is starting #useroperations w a focus on serial crystallography, time-resolved experiments & high-throughput crystallography. @MAXIVbiomax #Apply here! lu.varbi.com/en/what:job/job…
2
1
7
1,021
The Macromolecular Crystallography group seeks a #BeamlineScientist at #MicroMAX beamline! The beamline is starting #useroperations w a focus on serial crystallography, time-resolved experiments & high-throughput crystallography. @MAXIVbiomax #Apply here! lu.varbi.com/en/what:job/job…
5
1
9
1,957
Still time to apply for the postdoc and PhD positions in our ERC Synergy project, DynaPLIX (Dynamics of Protein–Ligand Interactions), that aims to combine MD, NMR and time-resolved crystallography. Apply before RNA day. Postdoc employment.ku.dk/faculty/?sh… PhD employment.ku.dk/phd/?show=1…
2
26
1
52
14,769
The PhD positions are in my group 🇩🇰 and are focused on molecular dynamics simulations 🕺💃, but will involve collaborations with Mikael Akke 🇸🇪 and Eike Schulz 🇩🇪. Please read the call for more about the experience we're looking for, as well as requirements and how to apply
2
4
900
Here's an #FBDD focused round-up of the @CHI_Healthtech Drug Discovery Chemistry conference in San Diego last week. Ways to find and assess covalent fragments, success stories, and a suite of techniques for E3 ligases and difficult targets practicalfragments.blogspot.…
3
2
841
Björn Walse retweeted
Tatiana Kutateladze’s group @CUAnschutz & collaborators identified the ZZ domain of the autophagic receptor p62 as the target of the innate defense regulator dusquetide and reveal the structural mechanism of dusquetide action doi.org/10.1016/j.str.2022.0…
1
4
Björn Walse retweeted
Open permanent position: instrumentation engineer to support and develop the MX beamlines @MAXIVLaboratory Join us and contribute to understanding biology and to development of new medicines and new biotechnology Last day to apply August 14th lu.varbi.com/se/what:job/job…
1
2
New PDB Deposition from I02 pdbe.org/7AMG
1
2
An engineered #CD80 variant fusion therapeutic, davoceticept (#ALPN-202), drives T-cell activation through PD-L1-dependent #CD28 co-stimulation and dual PD-L1/CTLA-4 checkpoint inhibition. @AlpineImmuneSci #CancerResearch @natrescancer nature.com/articles/s41467-0…
8
18
Excited to share the publication in @NatureComms of new preclinical data for our first-in-class #CD28 costimulator and dual CPI candidate, davoceticept, demonstrating our novel approach to enhance T cell activation and anti-tumor activity. Learn more: https://xitter.cf/t.co/cLstyahpbr
Three more serotonin receptors with structures out in Nature. Nice addition towards @icaro_simon s PhD thesis and great collaboration with Eric Xu and the team. Thanks to @EU_H2020, @lundbeckfonden & @novonordiskfond. #gpcr lnkd.in/ePDnNT8
5
2
35
Releasing the data from @SSI_dk to experts worldwide - quite a very different story emerges with no urgent drama in the mutations as such, but a warning of the dynamics in a large animal reservoir like mink and global traffic - great work by @AKiversen berlingske.dk/videnskab/gen-…
4
12
Don't forget today's #MultiPark Innovation Days talk from SARomics Biostructures AB's @bwalse! It's today at 13.00 in Belfrage Lecture Hall, BMC, D15. Check your e-mails for the abstract and Zoom link!
Friday MultiPark 📧-mail alert! #MultiPark Innovation Days 2020 is excited to welcome @bwalse on September 16th. As CEO, he will give a talk on the innovative work they do at SARomics Biostructures AB. Check your e-mail for more info! Company website: saromics.com/
1
2
New paper from our partners in Lund and Gdańsk ⁦@bwalse⁩ ⁦@mariahakansson⁩ ⁦@MAXIVLaboratory⁩ mdpi.com/1422-0067/21/14/489…
1
2
Björn Walse retweeted
Structural biology rocks. It’s moving at warp speed, racing vs the virus.
6
29
1
217